期刊文献+

贲门失弛缓症的诊治及管理策略

Diagnostic and therapeutic strategies for achalasia of the cardia
下载PDF
导出
摘要 贲门失弛缓症(achalasia of cardidia,AC)是一种原发性食管动力障碍性疾病,其诊断的主要依据包括临床症状、食管造影、食管动力学检查及上消化道内镜检查,食管高分辨率测压是金标准.随着新技术的兴起,AC的诊断方式更加丰富,三维建模或许可以促进AC的早期发现,内镜下功能性腔内成像探针可以提高诊断的准确率.常用的治疗方法有内镜下球囊扩张、腹腔镜Heller肌切开术、经口内镜下肌切开术(peroral endoscopic myotomy,POEM)等.POEM已成为目前应用最广泛的治疗方法,大幅提高了AC的临床治疗成功率.本文旨在结合近年来的研究进展,对AC的诊断和治疗进行综述. The diagnosis of achalasia of the cardidia(AC)is primarily based on clinical symptoms,esophagographic findings,esophagodynamic examination,and upper gastrointestinal endoscopic findings.High resolution manometry is considered the gold standard for diagnosis.With the advan-cement of new technologies,the diagnostic methods for AC have become more diverse,and three-dimensional modeling may facilitate early detection of AC.The use of endoscopic functional intracavity imaging probe can enhance diagnostic accuracy.Common treatment options include endoscopic balloon dilation,laparoscopic Heller myotomy,and peroral endoscopic myotomy(POEM).POEM has emerged as the most widely utilized therapeutic approach currently,significantly improving the clinical success rate in treating AC.This article provides a comprehensive review on recent research progress in the diagnosis and treatment of AC.
作者 任祥凤 于梓涵 宋文轩 孟庆国 陈鑫 Xiang-Feng Ren;Zi-Han Yu;Wen-Xuan Song;Qing-Guo Meng;Xin Chen(Department of Gastroenterology and Hepatology,Tianjin Medical University General Hospital,Tianjin 300052,China)
出处 《世界华人消化杂志》 CAS 2024年第8期545-555,共11页 World Chinese Journal of Digestology
关键词 贲门失弛缓症 诊断 治疗 营养不良 三维建模 Achalasia of the cardidia Diagnosis Treatment Malnutrition Three-dimensional modeling
  • 相关文献

参考文献1

二级参考文献20

  • 1Yasushi Torii,Yoshitaka Goto,Shinji Nakahira,Akihiro Ginnaga.Establishment of alternative potency test for botulinum toxin type A using compound muscle action potential (CMAP) in rats[J]. Toxicon . 2014
  • 2R. Niknam,J. Mikaeli,N. Fazlollahi,L. Mahmoudi,N. Mehrabi,S. Shirani,R. Malekzadeh.Ethanolamine oleate as a novel therapy is effective in resistant idiopathic achalasia[J]. Dis Esophagus . 2014 (7)
  • 3Lei Wang,Yi Sun,Weiping Yang,Paul Lindo,Bal Ram Singh.Type A botulinum neurotoxin complex proteins differentially modulate host response of neuronal cells[J]. Toxicon . 2014
  • 4Anna Latiano,Orazio Palmieri,Fabrizio Bossa,Tiziana Latiano,Giuseppe Corritore,Ermelinda De Santo,Giuseppina Martino,Antonio Merla,Maria Rosa Valvano,Antonello Cuttitta,Tommaso Mazza,Vito Annese,Angelo Andriulli.Impact of genetic polymorphisms on the pathogenesis of idiopathic achalasia: Association with IL33 gene variant[J]. Human Immunology . 2014
  • 5Zeeshan Ramzan,Ammar B. Nassri.The role of Botulinum toxin injection in the management of achalasia[J]. Current Opinion in Gastroenterology . 2013 (4)
  • 6Roberta Ravenni,Domenico Grandis,Alberto Mazza.Conversion ratio between Dysport and Botox in clinical practice: an overview of available evidence[J]. Neurological Sciences . 2013 (7)
  • 7Ann P. Tighe,Giampietro Schiavo.Botulinum neurotoxins: Mechanism of action[J]. Toxicon . 2013
  • 8Manuel Moretó,Enrique Ojembarrena,Angel Barturen,Ignacio Casado.Treatment of Achalasia by Injection of Sclerosant Substances: A Long-Term Report[J]. Digestive Diseases and Sciences . 2013 (3)
  • 9Wout O. Rohof,Guy E. Boeckxstaens.Treatment of the patient with achalasia[J]. Current Opinion in Gastroenterology . 2012 (4)
  • 10Dirk Dressler.Clinical applications of botulinum toxin[J]. Current Opinion in Microbiology . 2012 (3)

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部